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Abstract
This paper defines a collection of Drosophila deletion mutations (deficiencies) that can be systematically screened for
embryonic phenotypes, orphan receptor ligands, and genes affecting protein localization. It reports the results of deficiency
screens we have conducted that have revealed new axon guidance phenotypes in the central nervous system and
neuromuscular system and permitted a quantitative assessment of the number of potential genes involved in regulating
guidance of specific motor axon branches. Deficiency ‘‘kits’’ that cover the genome with a minimum number of lines have
been established to facilitate gene mapping. These kits cannot be systematically analyzed for phenotypes, however, since
embryos homozygous for many deficiencies in these kits fail to develop due to the loss of key gene products encoded
within the deficiency. To create new kits that can be screened for phenotype, we have examined the development of the
nervous system in embryos homozygous for more than 700 distinct deficiency mutations. A kit of ,400 deficiency lines for
which homozygotes have a recognizable nervous system and intact body walls encompasses .80% of the genome. Here
we show examples of screens of this kit for orphan receptor ligands and neuronal antigen expression. It can also be used to
find genes involved in expression, patterning, and subcellular localization of any protein that can be visualized by antibody
staining. A subset kit of 233 deficiency lines, for which homozygotes develop relatively normally to late stage 16, covers
,50% of the genome. We have screened it for axon guidance phenotypes, and we present examples of new phenotypes
we have identified. The subset kit can be used to screen for phenotypes affecting all embryonic organs. In the future, these
deficiency kits will allow Drosophila researchers to rapidly and efficiently execute genome-wide anatomical screens that
require examination of individual embryos at high magnification.
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Introduction
Most of the major findings that have emerged from research on
Drosophila were driven by the identification of mutations producing
a chosen phenotype via unbiased forward genetic screens. The
pioneering anatomical screen of Nusslein-Vollhard and Wieschaus
examined cuticle patterns of unhatched embryos bearing lethal
mutations induced by the chemical mutagen ethyl methanesulfo-
nate (EMS) [1]. The characterization of the genes found in this
screen defined many of the fundamental mechanisms that control
development in both insects and vertebrates.
Many other groups have since performed anatomical EMS
screens of embryos. In the 1990s, Corey Goodman’s group used
antibody staining of whole-mount embryos to identify genes
required for central nervous system (CNS) and motor axon
guidance [2,3]. These screens identified many interesting genes,
including roundabout (robo) and slit, which control axon guidance
across the CNS midline [4,5]. However, the necessity to screen
thousands of point mutant lines meant that axonal phenotypes had
to be detected by examination of embryos at low magnification
under a dissecting microscope. Subtle phenotypes could not be
found in this manner. It can also be difficult to identify the gene
responsible for a phenotype discovered in an EMS screen. P
element insertion screens allow easier identification of mutated
genes, but P element mutations are usually not nulls, and on
average have weaker embryonic phenotypes than EMS mutations
in the same genes.
Screens of deletion mutations, called deficiencies (Dfs), each of
which removes multiple genes, have also been used to find genes
required for embryonic development. Because many gene
products are maternally expressed and deposited in the egg,
where they can contribute to early development, embryos
homozygous for Dfs can sometimes develop to fairly late stages.
single-minded (sim), a gene required for midline glial fate determi-
nation, was identified through a Df screen [6,7]. Embryos were
stained with an antibody that labeled axons, and one Df was
identified for which homozygotes had a CNS that consisted of a
single line of axons running the length of the embryo. This
phenotype was found to be due to the absence of a single gene, sim.
Df screening has also been employed to identify closely linked
genes that have redundant functions. reaper (rpr), hid, and grim are
regulators of cell death in Drosophila that are encoded by linked
genes. A deletion that removed rpr, hid, and grim was found to
eliminate all cell death in the embryo, but single mutations
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affecting the individual genes do not produce this phenotype.
Thus, these cell death genes could only have been discovered by
examination of Df phenotypes [8]. Similarly, the closely linked
pyramus and thisbe genes, which encode partially redundant
fibroblast growth factor-related ligands, were found by identifying
a region whose deletion causes a failure of mesoderm spreading
[9,10].
Our group had devised methods to screen Df collections for
genes required for expression of orphan receptor ligands [11,12].
We realized that the Bloomington stock center Df ‘kit’ that existed
in 2002, when we began these experiments, was of limited utility
for screens requiring dissection and analysis of embryos. We thus
began a project to define new kits of publicly available Dfs that
could be used for ligand and antigen expression screens, as well as
for phenotypic screening. Here we describe these kits, and present
the results of screens that we have conducted for genes involved in
nervous system development. We have found a variety of central
nervous system (CNS) and motor axon guidance phenotypes, some
of which represent new phenotypic classes. The kits should
accelerate the work of investigators examining development of
other embryonic organs, because they will allow high-resolution
anatomical screens to be conducted much more rapidly than has
been possible in the past.
Results
Development of a deficiency kit to screen for orphan
receptor ligand genes
We initially used Df screening to search for ligands for the
receptor tyrosine phosphatase (RPTP) Lar. We fused the
extracellular (XC) domain of Lar to human placental alkaline
phosphatase (AP), which is a dimeric protein [13], and expressed
the resulting fusion protein (Lar-AP) using a baculovirus vector.
Lar-AP-containing cell supernatants were incubated with live-
dissected late stage 16 Drosophila embryos, and binding was
detected with secondary and tertiary antibodies. Lar-AP stains a
complex pattern, including CNS axons, midline glia, and muscle
attachment sites.
To identify genes required for Lar ligand expression, we crossed
green fluorescent protein (GFP) balancer chromosomes into the
270 lines in the Bloomington Df kit as it existed in 2002. We
dissected GFP-minus late stage 16 embryos and stained them with
Lar-AP. We found a Df that lacked Lar-AP muscle attachment site
staining, and used overlapping Dfs and insertion mutations to
identify the heparan sulfate proteoglycan (HSPG) Syndecan as the
Lar ligand encoded within this Df [11].
In the course of this work, we dissected, stained, and analyzed
embryos homozygous for every Df in the Bloomington kit. We
found that homozygotes for many of the Dfs failed to develop to
late stage 16, and thus could not be screened for ligand expression.
Failure to develop is often due to the loss of zygotic expression of a
single key gene under the Df. It is thus possible to reduce the sizes
of these ‘unscreenable’ regions using other publicly available
overlapping Dfs, examining homozygotes for each Df and finding
those that develop well enough to be screened. We also tried to
replace Bloomington kit Dfs that were only mapped to cytological
resolution with molecularly mapped Dfs. After completing many
iterations of this process, involving the dissection and staining of
embryos from more than 700 Df lines, we were able to define a
new kit of 423 lines, which allows screening of 80–90% of the
genome for Lar-AP staining, or staining with other reagents that
recognize CNS axons.
In creating this kit, we had two goals that had to be balanced
against each other. The first was to assemble a set of lines that
would have the highest possible percentage of Dfs for which
homozygotes developed relatively normally. The second was to
cover the maximum possible percentage of the genome with a
minimum number of Dfs. The present kit is a compromise, as it
still has a substantial number of Dfs that cause major
developmental defects. However, we have tried to reduce the
regions that are only covered by Dfs of this kind to the minimum
size possible, by iterative screening of Dfs covering smaller and
smaller portions of the ‘problem regions’ (see notes in Table S1). In
some cases, we have reached the limit of our ability to reduce the
sizes of the problem regions using existing Dfs. In other cases, it
might be possible to subdivide the Dfs further to obtain greater
coverage by Dfs that confer more normal development. However,
this would mean that the resulting kit would contain more lines
and would consequently be more time-consuming to screen.
We classified phenotypes for late stage 16 embryos homozygous
for Dfs in the kit as ‘mild’, ‘moderate’, ‘severe’, or ‘very severe’.
Homozygotes for 394 Dfs, corresponding to 82% of the genome
(233 mild+83 moderate+78 severe) have a recognizable pattern of
CNS axons and exhibit clear Lar-AP staining, as well as staining
with the CNS axon marker monoclonal antibody (mAb) BP102
[2]. The 25 very severe Dfs that remain in the kit, representing
another,10% of the genome, are marginally screenable with Lar-
AP and BP102 (Table S1). The remaining ,8% of the genome
cannot be examined at present using Df screening, because
embryos homozygous for Dfs in these regions fail to develop any
recognizable late embryonic structures and cannot be dissected.
We expect that the mild, moderate, and severe Df lines should also
be readily screenable for ligands expressed outside the CNS,
although development of the desired tissue will need to be
evaluated for each Df by double-staining with an appropriate
antibody, as we did for the CNS with BP102.
We have now completed the screening of this new kit with four
different RPTP-AP fusion proteins, corresponding to the XC
domains of Lar, Ptp10D, Ptp69D, and Ptp99A. Here we show
results from the Ptp99A ligand screening as an example of the
method. In wild-type late stage 16 embryos, 99A-AP (visualized
with Alexa 488-coupled anti-rabbit IgG) stains CNS axons, the
tracheae, and the salivary glands (Figures 1A, G). CNS axons were
simultaneously visualized by staining with BP102, followed by
Alexa 568-conjugated anti-mouse IgG. BP102 stains most or all
CNS axons, but only within the boundaries of the CNS. Motor
axons lose BP102 staining after they leave the CNS. The BP102
pattern thus resembles a ladder, with two commissural tracts
(anterior and posterior) crossing the midline in each segment, and
two longitudinal tracts extending the length of the embryo
(Figures 1B, H).
We found three Dfs for which homozygotes have reduced 99A-
AP staining on CNS axons, but retain normal staining of the
tracheae. Df(2L)Exel7042 and Df(3R)Cha7 both eliminate staining
(Figures 1D, I, K). Df(3R)Exel6176 embryos have reduced axonal
staining, and cell bodies within the CNS show more staining than
in wild-type(Figure 1M). The lack of CNS axon staining in these
Df homozygotes is not due to the absence of CNS axons, since
BP102 staining reveals that axons are still present (Figures 1E, J, L,
N). The decrease in 99A-AP axon staining is a robust phenotype
that allows gene mapping, and we have used overlapping Dfs and
insertion mutations to identify single genes under each of these
three Dfs whose loss accounts for the reduction in staining. These
genes are: repo, gcm, and Cal1 (CG5148). repo and gcm encode
transcription factors that control glial fate determination. The
requirement for these genes demonstrates that a signal from glia to
neurons is necessary for expression of the axonal Ptp99A ligand(s).
We have confirmed this by killing glia and showing that this also
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eliminates axonal 99A-AP staining (data not shown). We do not
yet understand the role of Cal1, which encodes a protein required
for metaphase chromosome alignment in cultured cells [14,15].
A deficiency kit for screening for axon guidance
phenotypes
In the course of our screen for genes required for RPTP ligand
expression, we noted that homozygotes for 233 of the Dfs in our
kit, corresponding to,50% of the genome, developed a normal or
almost normal pattern of CNS axons as visualized by BP102, and
also had relatively normal overall embryonic morphologies. 217 of
these Dfs can be maintained over GFP balancers, so that
homozygous embryos can be easily identified. We reasoned that
these lines (classified as ‘mild’) could define a kit that would allow
systematic screening for any embryonic phenotype that can be
visualized by staining live-dissected embryos with antibodies
(Table S2). We decided to search for motor axon guidance
phenotypes by staining homozygotes for mild Dfs with mAb 1D4,
which recognizes the cytoplasmic domain of the transmembrane
form of Fasciclin II (FasII) [3]. In late stage 16 embryos, 1D4 stains
all motor axons and three longitudinal axon bundles on each side
of the CNS. We also stained a subset of the Dfs with moderate
phenotypes with 1D4 in order to find new CNS phenotypes (see
below).
Each abdominal hemisegment (A2–A7) of a Drosophila embryo
contains about 36 motor neurons, which innervate 30 body wall
muscle fibers in a stereotyped pattern. Motor axons leave the CNS
within two nerve roots: the segmental nerve (SN) root and the
intersegmental nerve (ISN) root. These nerve roots further divide
into five major pathways, known as segmental nerve a (SNa),
segmental nerve c (SNc), intersegmental nerve (ISN), interseg-
mental nerve b (ISNb) (also known as SNb), and intersegmental
nerve d (ISNd) [16]. Two axons leave the CNS separately from the
ISN and SN, and these connect to the axon of the peripheral
lateral bipolar dendrite (LBD) neuron to form the transverse nerve
(TN).
In the 1990s, 1D4 was employed for a large EMS screen of the
autosomes [3,17] for genes conferring embryonic motor axon
guidance phenotypes. Because a point mutant screen requires the
analysis of thousands of lines, these phenotypes were discovered
through examination of whole-mount embryos at low power under
a dissecting microscope. This allowed the identification of
mutations conferring relatively severe ISN and ISNb phenotypes,
which could be seen at low magnification. However, mutations
affecting the other pathways, such as SNa and SNc, or mutations
conferring more subtle ISN and ISNb phenotypes, could not be
identified in this screen.
In our screen, we dissected live late stage 16 embryos
homozygous for most of the balanceable mild Dfs (190 in total),
fixed them after dissection, then stained with 1D4, followed by
Alexa 488 anti-mouse secondary and rhodamine-phalloidin to
visualize muscle structure and the CNS axon ladder. We
examined these embryos under a compound microscope, using a
406water-immersion objective. In this way, we could perform a
detailed analysis of all of the motor pathways, and simultaneously
visualize muscle structure.
To screen for motor or CNS axon guidance phenotypes, we
typically examined five dissected late stage 16 embryos, or
approximately 50 hemisegments. A Df was scored as phenotyp-
ically abnormal if multiple hemisegments in each embryo
exhibited defects (.20% penetrance). 82 of the mild Dfs had no
phenotypes with penetrances above this threshold. The remainder
displayed axonal or muscle phenotypes, or both (Table S3).
Examples of CNS phenotypes
In late stage 16 wild-type embryos, 1D4 stains three parallel
axon bundles on each side of the midline (Figure 2A). At this stage,
FasII is not seen on the commissures. Since most longitudinal
axons cross the midline at some point in their trajectory, this
means that FasII is restricted to the longitudinal portions of a
subset of CNS axons. At earlier stages in development, FasII also
labels some commissural pathways.
We found a variety of CNS phenotypes in our screens. Here we
show some interesting examples of robo-like phenotypes, analyzed
by 1D4 staining. robo encodes an immunoglobulin (Ig) domain
superfamily member that is a neuronal receptor for the midline
glial ligand Slit, which functions as a repellent in this context [4,5].
In the absence of Robo, 1D4-positive axons have reduced
sensitivity to the repulsive Slit signal. As a consequence, they
cross the midline repeatedly, forming trajectories with a circular
appearance (Figure 2B). We found several regions of the genome
whose deletion results in phenotypes resembling that of robo,
although all of the Df phenotypes are more severe than those of
robo single mutants.
Df(3R)Exel7310, Df(1)BSC627, and Df(2L)Exel8041 embryos
all have midline guidance defects in which FasII-positive axons
appear to form circles around the midline (Figures 2C, E, F). Each
Df has its own characteristic phenotype. Df(3R)Exel7310 deletes a
candidate gene, shadow (sad), that has a published robo-like
phenotype [18]. To determine whether the phenotype of this Df
is due to loss of sad, we crossed the sad1 point mutation to the Df.
The resulting transheterozygous embryos also have robo-like
phenotypes, although they are much weaker than those of Df/
Df embryos (Figure 2D). Perhaps sad1 is not a null mutation, or
other genes under the Df contribute to the phenotype. The other
two Dfs appear to define new genes whose absence causes axons to
circle around the midline. We have used overlapping Dfs to map
the gene responsible to a smaller region within Df(1)BSC627. The
Df(1)BSC627 phenotype was mapped to the 7F7-8A2 interval
using Df(1)BSC592 (has the phenotype when transheterozygous
with Df(1)BSC627) and Df(1)Exel6241 (does not have the
phenotype).
Figure 1. Deficiencies that reduce 99A-AP fusion protein staining of CNS axons. Confocal maximum intensity projections of late stage 16
live-dissected Drosophila embryos visualized by immunofluorescence (206objective). Anterior is up. Panels A–F show the ventral nerve cord and one
half of the body wall. Panels G–N show a portion of the ventral nerve cord. In Panels A–F scale bar equals 20 mm. In Panels G–N scale bar equals
10 mm. (A) 99A-AP fusion protein staining pattern in a wild-type embryo. The arrow indicates 99A-AP fusion protein binding to axons in the ventral
nerve cord while the arrowhead indicates binding to tracheae. (B) mAb BP102 staining labels commissures and longitudinal connectives of the
ventral nerve cord (arrow) in the same embryo. (C) Wild-type merged image (99A-AP, green; BP102, magenta). (D) 99A-AP fusion protein staining is
absent from the ventral nerve cord in a Df(2L)Exel7042 embryo, while tracheal staining remains unaltered (arrowhead). (E) mAb BP102 staining in
Df(2L)Exel7042 reveals that axons are still present in the ventral nerve cord (arrow). (F) Df(2L)Exel7042 merged image. (G and H) wild-type embryo
stained with 99A-AP fusion protein and mAb BP102. (I and J) Df(2L)Exel7042 embryo stained with 99A-AP fusion protein and mAb BP102. (K and L)
Df(3R)Cha7 embryo lacks 99A-AP fusion protein staining of CNS axons, but has axons as evidenced by BP102 staining (L). (M and N) Df(3R)Exel6176
embryo has reduced 99A-AP fusion protein binding to CNS axons, but has axons as evidenced by BP102 staining (N). Note that there appears to be
more staining of cell bodies in the CNS than in (I) and (K).
doi:10.1371/journal.pone.0012288.g001
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Figures 2G and H show Dfs for which 1D4-positive axons
abnormally cross the midline without circling. In Df(3L)HD1
embryos (Figure 2G), axons in the inner 1D4 longitudinal pathway
cross the midline. Several other Dfs also have this kind of
phenotype. Df(3R)Exel6162 produces an interesting phenotype in
which the CNS has a normal organization, but one of the
commissural pathways is now 1D4-positive (Figure 2H). This
phenotype could arise from abnormal guidance of a small subset of
longitudinal 1D4 axons across the midline, or from ectopic
expression of FasII on a commissural axon bundle.
SNa guidance phenotypes
The SNa exits the CNS in the SN nerve root. SNa has a
characteristic bifurcated morphology in wild-type late stage
embryos, with a dorsal (or anterior) branch and a lateral (or
posterior) branch. The SNa bifurcation point is at the dorsal edge
of muscle 12. The dorsal branch of the SNa innervates muscles
21–24, while the lateral branch innervates muscles 5 and 8
(Figures 3A, E). Each mild Df was screened for the presence of a
bifurcated SNa pathway. Of the 190 lines screened, 20 had SNa
bifurcation defects (Table 1).
The SNa pathway develops later than the other motor axon
pathways, and is also fainter than the ISN or ISNb in 1D4-stained
preparations. Live dissections can only be performed up to late
stage 16, because older embryos fail to stick to the glass slides. We
could not be sure that SNa defects seen in the live dissections were
not due to developmental delays. Accordingly, we did not attempt
to quantitatively score SNa bifurcation failures in live-dissected
embryos. Instead, we generated early stage 17 whole-mount
embryos stained with 1D4, using horseradish peroxidase (HRP)
Figure 2. Examples of CNS phenotypes in deficiency homozygotes. (A–H) are confocal maximum intensity projections of mAb 1D4
immunofluorescence in live-dissected stage 16 embryos (206objective). Anterior is up. Scale bar equals 10 mm. (A) wild-type embryonic nerve cord
showing three parallel longitudinal bundles on either side of the midline and no FasII positive bundles crossing the midline. (B) Staining of FasII in
robo1 reveals a phenotype where axons repeatedly cross the midline in a circular fashion (arrow). This is a robo1 phenotype of ‘average’ strength. Most
published robo images are of unusually strong phenotypes. (C) Df(3R)Exel7310 embryonic nerve cord has a phenotype where axons appear to circle
the midline (arrow). (D) sad1/Df(3R)Exel7310 has a phenotype in which FasII positive axons cross the midline. It is weaker than the phenotype in (C),
however. (E) Df(1)BSC627 and (F) Df(2L)Exel8041 also have phenotypes where axons appear to circle the midline (arrows). Each of the three
phenotypes has a unique overall appearance, however. (G) In Df(3L)HD1, FasII positive axons of the inner fascicle cross the midline inappropriately
(arrows). (H) Df(3R)Exel6162 has a phenotype in which the nerve cord has a normal geometry, but one commissural bundle per segment is FasII
positive (arrow).
doi:10.1371/journal.pone.0012288.g002
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immunohistochemistry for detection, for a subset of the Dfs that
had strong SNa defects. These were then dissected after clearing in
glycerol and visualized with differential interference contrast (DIC)
optics. Previously reported SNa phenotypes (e.g. Ptp52F [19])
usually involve the loss of either the dorsal or lateral branch with
an approximately equal probability. Df(3R)BSC42 causes a typical
SNa bifurcation defect in which the dorsal, lateral, or both
branches are missing with nearly the same penetrances (3, 3, and
4% respectively in HRP-stained preparations; Figure 3I). Howev-
er, Df(2R)BSC19 (56F12--14;57A4) produces a unique phenotype
in which only the dorsal branch of SNa is absent or malformed
(Figures 3B–D, G, and I). When we examined dissected whole-
mount embryos from this line, we found that the dorsal branch of
SNa was completely missing in 25% of hemisegments (n = 155)
while the lateral branch is almost always present. Figure 3 shows
three different Df(2R)BSC19 phenotypes affecting the dorsal
branch: dorsal branch completely absent (Figure 3B), dorsal
branch truncated (Figure 3C), and dorsal branch reduced to one
axon (Figure 3D). Both SNa branches are present and have a
normal thickness in .98% of hemisegments in wild-type embryos
at the same stage (n = 135) (Figure 3I).
We examined whether the loss of the dorsal SNa branch in
Df(2R)BSC19 embryos might be due to absence or malformation
Figure 3. SNa defects in Df(2R)BSC19 and Df(3R)BSC42. (A–D) each show 2 abdominal hemisegments from late stage 16 embryos fixed and
stained with mAb 1D4 using horseradish peroxidase immunohistochemistry (636oil immersion objective and DIC optics). Anterior is to the left and
dorsal is up. (A) The wild-type SNa has a characteristic bifurcated morphology where the dorsal branch innervates muscles 21–24 and the lateral
branch innervates muscles 5 and 8. The bifurcation point is just dorsal to muscle 12 (labeled) and is indicated by an asterisk. (B) Df(2R)BSC19
abdominal hemisegments lack the dorsal branch of the SNa (asterisk) while the lateral branch appears thicker than wild-type (arrowhead). (C)
Df(2R)BSC19 abdominal hemisegment where a short dorsal branch has extended but not reached the target muscles (arrow). (D) Df(2R)BSC19
abdominal hemisegments in which only one axon has extended dorsally (arrows). The lateral branch appears thicker in the left hemisegment
(arrowhead). (E–H) Maximum intensity confocal projections of stage 16 live-dissected embryos double stained with 1D4 and rhodamine phalloidin
(636oil immersion objective). Anterior is to the left and dorsal is up. Scale bar equals 10um. (E–F) wild-type abdominal hemisegments showing a
bifurcated SNa (asterisk). The target muscles of the dorsal branch of SNa (muscles 21–24) are indicated by brackets in (F). (G–H) Df(2R)BSC19
abdominal hemisegments showing the absence of the dorsal branch of SNa (asterisks) but the presence of target muscles 21–24 (brackets). (I) Chart
showing quantification of various SNa defects in wild-type, Df(2R)BSC19 and Df(3R)BSC42. The number of abdominal hemisegments A3–A7 scored is
as follows: wt = 135, Df(2R)BSC19 = 155, Df(3R)BSC42 = 126.
doi:10.1371/journal.pone.0012288.g003
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of its target muscles. Using phalloidin staining in live-dissected
embryos, we determined that in 25% of abdominal hemisegments
(n = 88) one or more of the dorsal branch target muscles (21–24) is
not present, and this could account for the absence of the branch
in these hemisegments. In live-dissected preparations, the SNa
phenotype appears to be much stronger, so that 87% of
hemisegments have a missing dorsal branch. In most of these
(71% of total hemisegments), we find that the target muscles are in
the proper place, yet SNa still fails to bifurcate (Figures 3G, H).
The difference in the apparent strength of SNa phenotypes
between live-dissected embryos stained fluorescently and dissected
whole-mount embryos stained by HRP immunohistochemistry
likely results primarily from the greater age of the whole-mount
embryos. This was observed for other Dfs as well.
In many of the hemisegments in Df(2R)BSC19 embryos where
the dorsal branch is missing or contains only one axon, there may
be too many axons in the lateral branch, as this branch is
abnormally thick (Figures 3B, D). In summary, the phenotype of
Df(2R)BSC19 is likely to be a complex mixture of defects in axon
guidance, defects in differentiation of lateral muscles, and
developmental delays. We have narrowed down the responsible
region of this Df to ,6 genes, using Df(2R)BSC400 and
Df(2R)Exel7163 (have the phenotype) and Df(2R)Exel7162 (does
not have the phenotype). Whether all phenotypes are caused by
the absence of a single gene remains to be determined.
ISNb guidance phenotypes
The ISNb contains the axons of the RP1, RP3, RP4, and RP5
neurons, among others. These axons cross the midline and exit the
CNS in the ISN nerve root. They must defasciculate from the
common ISN pathway at the ‘exit junction’ in order to enter the
ventrolateral muscle (VLM) field. Once there, they innervate
muscles 6, 7, 12, 13, 14, and 30 (Figures 4A, C). Of the 190 lines
screened, 9 were found to have strong ISNb defects. These ISNb
phenotypes include ‘bypass’, in which ISNb axons fail to separate
from the ISN and grow past the VLMs, and ‘stall’, in which axons
enter the VLM field but fail to reach the normal ISNb termination
point at the ventral edge of muscle 12 (Figure 4A). We also found
some structural abnormalities in the ISNb that could not be
grouped into one of these classes.
Df(3L)Exel6087 produces a highly penetrant stall of the ISNb at
the dorsal edge of muscle 6, which corresponds to the ventral edge
of muscle 13. We quantified this phenotype in fixed-dissected
embryos stained by HRP immunohistochemistry, and found that
in 63% of hemisegments (n = 144) the ISNb fails to extend across
muscle 13 (Figures 4B, D). Muscles 12 and 13 are present and
appear normal both by phalloidin staining and DIC optics.
Df(2L)Exel7080 causes a bypass phenotype in which 14% of
hemisegments (n = 168) have no ISNb axons that grow into the
VLM field (Figures 4B, E, F). We have identified Mtp (CG9342) as
the single gene under this Df whose loss is responsible for the
bypass phenotype (A. Cording and A.P.W., unpublished results).
Df(2L)ED1317 has an interesting structural phenotype in which
ISNb axons form loops on muscles 6 and 7 (Figure 4H). When we
examined Df(2L)ED1317 embryos stained as whole-mounts and
visualized by HRP immunohistochemistry, we could not see this
phenotype. It is likely that fine axonal branches such as those in
the loops can be more readily seen in fluorescent preparations,
because they can be damaged by the reactive oxygen species
produced in the HRP reaction. Also, the aspect of the phenotype
in which the axons failed to grow across muscle 13, which should
have appeared as a stall in preparations stained by HRP
immunohistochemistry, may have corrected itself later in devel-
opment, so that it was no longer evident in the older embryos that
were stained as whole-mounts. These results, together with
observations we have made on other Dfs, show that some
phenotypes that are readily seen in fluorescently stained embryos
that are fixed after live dissection cannot be detected in dissected
whole-mount embryos stained by HRP immunohistochemistry.
Eight of the 9 regions whose deletion selectively affects ISNb
guidance without visibly altering muscle development appear to
define genes that have not been previously shown to affect motor
axons. We examined the relationships between the Dfs and the
locations of previously identified genes affecting the ISNb, to
determine why we did not recover more Dfs spanning known
ISNb guidance genes. We did find Dfs spanning one known gene,
sidestep (side), but had classified these as affecting multiple pathways,
since side mutants also have SNa and ISN defects [17]. For other
known ISNb axon guidance genes with high-penetrance mutant
phenotypes, the Df in our complete kit that spanned the gene was
not within the subset of mild Dfs. For example, the Lar gene could
not have been discovered using the mild Df kit, because the screw
gene is embedded in one of its introns. Deletion of screw causes
early developmental failure [20]. The only Df in our complete kit
that removes Lar sequences also spans screw, and thus has a very
severe phenotype.
Requirement of the glial cells missing genes for ISNb
guidance
Df(2L)Exel7042 has an ISNb phenotype that is a mixture of
stall, bypass, and absence, in which there is no ISNb at all (12, 8,
and 17% of hemisegments, respectively; n = 118) (Figure 4B). The
CNS has a wavy 1D4 pattern with occasional breaks in the
longitudinal tracts (Figure 5B). When we assessed the genes that
are deleted by this molecularly mapped Df, two obvious
candidates were found: glial cells missing (gcm) and glial cells missing
2 (gcm2). gcm and gcm2 are transcription factors that are expressed
in all glia except for midline glia and are required for glial cell fate
determination [21,22,23]. In the absence of Gcm protein, some
presumptive glial cells become neurons. When Gcm or Gcm2 is
ectopically expressed in neurons, some of them become glia
[21,22,24,25]. gcm therefore acts as a molecular switch between the
neuronal and glial cell fates. gcm and gcm2 have largely overlapping
expression patterns, with gcm being expressed at much higher
levels than gcm2. In gcm mutants, a few glial cells remain, usually
those in which gcm2 expression is strongest. In the absence of both
Gcm proteins, no glial cells are found [24,25].
CNS axon guidance phenotypes have been previously observed
in gcm mutants, including breaks in the longitudinal fascicles and
abnormal trajectories of the pioneer axons of both the ISN and SN
nerve roots [21,22,23,26,27]. Motor axon pathways usually
develop normally in gcm mutants, although a published image of
a gcm embryo has a missing ISNb in one hemisegment [27]. When
we stained gcm null alleles with 1D4, we found that ISNb is
affected, but with a much lower penetrance than in
Df(2L)Exel7042 embryos, and the missing ISNb phenotype is
almost never observed (data not shown). Thus, the deletion of both
gcm and gcm2 by Df(2L)Exel7042 could account for the severity of
its ISNb phenotype. We also examined homozygotes for another
Df which deletes both gcm and gcm2, Df(2L)200, as well as
Df(2L)Exel7042/Df(2L)200 transheterozygotes. Homozygotes for
a very small Df, Df(2L)ED684, which deletes only 7 genes,
including gcm and gcm2, were also tested. In all of these cases, we
saw the same ISNb defects as in Df(2L)Exel7042, with similar
penetrances (data not shown).
To examine how the absence of glia affects the ISNb, we stained
Df(2L)Exel7042 embryos with an antibody to Fasciclin III (FasIII),
which is a marker for the cell bodies and proximal axons of the ISNb
Screening Dfs for Phenotype
PLoS ONE | www.plosone.org 7 August 2010 | Volume 5 | Issue 8 | e12288
Figure 4. Examples of ISNb defects in deficiency homozygotes. (A) Schematic showing the axons of the of ISNb and their muscle targets in
wild-type. Axons of the ISNb (blue) defasciculate from the ISN (red) at the exit junction (EJ) and enter the ventrolateral muscle field (green). The ISNd
is in olive green. First panel is a side view with internal to the left. The second panel is a top view with anterior to the left and dorsal up. Two types of
ISNb defects are illustrated in the third and fourth panels. The first defect is a stall of the ISNb where it does not project beyond the dorsal edge of
muscle 6. The second defect is bypass, in which the axons of the ISNb do not enter the muscle field and grow dorsally past their normal muscle
targets. Bypass phenotypes can represent a failure of ISNb axons to defasciculate from the ISN (fusion bypass), or successful defasciculation followed
by a failure to enter the muscle field (parallel bypass). (B) Chart showing quantification of deficiencies with various types of ISNb defects. The number
of abdominal hemisegments A3–A7 scored is as follows: wt = 139, Df(3L)Exel6087 = 144, Df(2L)Exel7080 = 168, Df(2L)Exel7042 = 118. (C–F) each
show abdominal hemisegments from late stage 16 embryos fixed and stained with mAb 1D4 using horseradish peroxidase immunohistochemistry
(636oil immersion objective and DIC optics). Anterior is to the left and dorsal is up. (C) ISNb in a wild-type embryo. The projection onto muscles 6
and 7 is indicated by an arrow. The projection onto muscles 12 and 13 is indicated by an arrowhead. The muscles are labeled with numbers. (D) ISNb
in an embryo from Df(3L)Exel6087 showing a stall at the boundary between muscles 6 and 13 (arrow). Arrowhead indicates the normal ISNb
termination point at the muscle 12/13 junction. The muscles are present and look wild-type and are labeled with numbers. (E–F) ISNbs in
Df(2L)Exel7080 embryos showing bypass phenotypes (arrows). (G–H) are confocal maximum intensity projections from stage 16 live dissected
embryos fluorescently stained with mAb 1D4 and rhodamine-phalloidin. These embryos are younger than in panels C–F because the loop phenotype
in panel H is more evident at this stage. Scale bar equals 10 mm. (G) Three hemisegments of a wild-type embryo, showing ISNb (arrows) projecting
normally into the muscle field. (H) Three hemisegments of a Df(2L)ED1317 embryo, where ISNb forms looping structures on the target muscles
(arrows). This phenotype was not visible when embryos were fixed, dissected, and stained with the same antibody using HRP immunohistochemistry.
doi:10.1371/journal.pone.0012288.g004
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neurons RP1, RP3, RP4 and RP5 [28]. In wild-type embryos,
FasIII staining reveals a regular pattern in which RP axons cross the
midline and then extend posteriorly for a short distance before
entering the ISN root (Figure 5D). In Df(2L)Exel7042 embryos, a
variety of defects were seen that could account for the different
classes of guidance errors we see in ISNb (Figure 5E). We found that
in many segments of the embryos extra cells express FasIII. This is
likely due to the fate switches from glial to neuronal that occur in the
absence of gcm and gcm2 function. We also observe that in some
segments neurons of the RP cluster fail to extend axons. In other
segments they extend axons that enter the longitudinal tracts, but
then exit the CNS in the wrong place or never exit at all. In some
cases the axons grow anteriorly rather than posteriorly along the
longitudinal tracts. All of these phenotypes could result in the loss of
the ISNb in the periphery, as well as contributing to the observed
breaks in the longitudinal tracts.
Are the defects we see in Df(2L)Exel7042 due to a lack of glial
cells, or to loss of some other function of gcm and gcm2? In order to
test whether glia are required for ISNb axon guidance we
examined reversed polarity (repo) mutants. repo encodes a transcription
factor that is downstream of gcm and is also required for glial cell
fate [21,29,30,31]. In the absence of Repo, few glial cells
differentiate. We stained embryos homozygous for a null allele
of repo with 1D4. We found that the longitudinal axon tracts in repo
embryos are wavy and have breaks (Figure 5C). There are extra
midline cells expressing FasIII in some segments. We also observed
guidance errors with anti-FasIII in which RP axons turn anteriorly
along the longitudinal pathway. However, these defects are not as
penetrant as when gcm and gcm2 are both deleted (Figure 5F). In
the periphery, the ISNb is usually normal in repo embryos,
although there are rare stall phenotypes (Figure 5I). This result
might be explained by the fact that although repo is required for
Figure 5. CNS and motor axon guidance phenotypes in mutants affecting glial development. (A–C) are confocal maximum intensity
projections of the CNS in stage 16 live-dissected embryos stained with mAb 1D4 by immunofluorescence. Anterior is up. Scale bar in F equals 10 mm.
(A) Ventral nerve cord of a wild-type embryo where mAb 1D4 labels 3 longitudinal bundles on either side of the midline. (B) Df(2L)Exel7042 embryo
where breaks in the outer fascicle are evident in the longitudinal bundles (arrow). (C) repo3702 embryo where ventral nerve cord appears disorganized.
(D–F) are confocal maximum intensity projections of stage 16 live dissected embryonic CNS showing FasIII immunofluorescence. Scale bar equals
10 mm. (D) FasIII staining in a wild-type embryo reveals neurons of the RP cluster indicated by an arrow and their proximal projections into the
periphery indicated by an asterisk. These axons cross the midline and then project posteriorly before leaving the nerve cord. (E) Df(2L)Exel7042
embryo where FasIII staining shows a very disorganized CNS. Axons sometimes project normally (asterisk), project posteriorly and never leave the
CNS (arrowhead), or project anteriorly instead of posteriorly (double arrow). Some neurons never send out axons (brackets). (F) repo3702 embryo
where more cells than normal express FasIII (arrow). Axons occasionally project anteriorly instead of posteriorly, but the projections of most axons are
normal (asterisk). (G–I) are confocal maximum intensity projections from live-dissected stage 16 embryos stained fluorescently with mAb 1D4 and
rhodamine conjugated phalloidin. Anterior is to the left and dorsal is up. The scale bars are equal to 10 mm. (G) Two hemisegments of a wild-type
embryo. Projection of the ISN is labeled with an asterisk. ISNb projections onto target muscles are indicated by an arrow. (H) Two hemisegments of
Df(2L)Exel7042 embryo. The ISN projects normally (asterisk), but the ISNb is missing from the left hemisegment. The SN root is at an abnormal
position (double arrow). See bar graph in Figure 4 for penetrance of the various ISNb defects in this deficiency line. (I) Two hemisegments from a
repo3702 embryo. In the left hemisegment, the ISNb stalls on muscle 6, and appears to be thinner than usual (arrow). Such phenotypes are rare in repo
mutants.
doi:10.1371/journal.pone.0012288.g005
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normal glial cell fate, in the absence of repo glia still begin to
differentiate and express some glial antigens [29,30,31].
Dfs causing changes in antigen expression
Another potential use of Df screening would be to find genes
required for normal cellular or subcellular expression of proteins
that can be visualized by antibody staining. In the course of our
examination of Df homozygotes by 1D4 staining, we found two
Dfs for which homozygotes (or hemizygotes) lack 1D4 antigen.
One of these, Df(1)C128, is shown here (Figure 6D). Df(1)C128
embryos clearly contain CNS axons, as shown by rhodamine-
phalloidin staining (Figure 6E), and they also stain with BP102
(data not shown). Df(1)C128 does not delete the FasII gene, and
we confirmed that the line does not harbor a FasII mutation by
complementation testing. The most likely explanation for the loss
of FasII expression is perhaps that Df(1)C128 deletes a gene
encoding a transcription factor necessary for production of FasII
mRNA. Embryos homozygous for Df(3R)Exel7310 display 1D4
staining on cells in the periphery that normally do not exhibit
staining. These are large, flat cells just anterior to the LBD neuron
(Figures 6I, J). We do not know the identities of these cells. They
appear to be internal to the epithelial layer, and they do not have
morphologies like those of muscles or sensory neurons. Two
possible explanations for this the presence of this ectopic 1D4
staining are: 1) the Df deletes a gene encoding a repressor that
prevents the FasII gene from being transcribed in these cells; 2) it
removes a gene whose product normally cleaves FasII off the
surfaces of these cells. Other models are also possible.
Discussion
In this paper, we define new kits of publicly available Dfs that
can be used for a variety of phenotypic screens. A set of ,400 Dfs
(the ‘complete kit’) for which homozygotes develop well enough to
have a recognizable CNS and body walls encompasses 82% of
polytene chromosome bands (Table S1). This kit can be screened
for orphan receptor ligands (Figure 1) and antigen expression
(Figure 6). A subset of the complete kit, covering ,50% of
polytene chromosome bands, contains 233 lines with ‘mild’
phenotypes, for which body walls have a wild-type morphology
and the CNS has a relatively normal structure (Table S2). This
subset kit can be used to screen for regions of the genome whose
Figure 6. Deficiencies causing loss or ectopic expression of 1D4 antigen. Panels A–F are maximum intensity confocal projections of stage 16
live-dissected embryos double-stained with mAb 1D4 and rhodamine-phalloidin (206 objective). Anterior is up. Scale bar equals 10 mm. (A) 1D4
staining in a wild-type embryo. (B) Phalloidin staining in a wild-type embryo. (C) Wild-type merged image (1D4, green; phalloidin, magenta). (D) 1D4
staining in a Df(1)C128 embryo. The image is black because these embryos completely lack 1D4 antigen. (E)Phalloidin staining in a Df(1)C128 embryo,
showing than CNS axons are present. (F) Df(1)C128 embryo merged image. Panels G and I are confocal maximum intensity projections of stage 16
live-dissected embryos stained with 1D4 (636objective). Anterior is to the left and dorsal is up. Scale bar equals 7 mm. Panels H and J are equivalent
to the boxed areas in G and I. (G) 1D4 staining in 3 abdominal hemisegments in a wild-type embryo. FasII expression is mostly restricted to neurons,
although there is some weak staining of other cell types. The LBD neuron is indicated by an arrow. (H) Detail of boxed area in G. The LBD is indicated
by an arrow. (I) 1D4 staining in 3 abdominal hemisegments in a Df(3R)Exel7310 embryo. Bright FasII expression is seen on non-neuronal cells,
including flat cells (arrowhead) adjacent to the LBD (arrow). Other 1D4-expressing cells are located more dorsally, just anterior to the ISN (double
arrowhead). (J) Detail of boxed area in (I). The LBD is indicated by an arrow. The bracket indicates the group of cells that ectopically express 1D4
antigen.
doi:10.1371/journal.pone.0012288.g006
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deletion confers specific embryonic phenotypes. We screened it for
axon guidance defects, and identified many new regions
containing genes necessary for establishment of motor axon and
CNS pathways (Figures 2–5).
Development, characterization, and use of the ‘complete’
Df kit
Our initial screen for orphan receptor ligands was performed
with the Bloomington Df kit as it existed in 2002 [11]. This kit
contained a large number of Dfs for which homozygotes failed to
develop, and most of the Dfs were only defined at cytological
resolution. To create a more useful kit for phenotypic screening,
we analyzed hundreds of additional Dfs for phenotype and ligand
staining, so as to define the smallest possible collection of Dfs that
would allow genome-wide ligand and phenotype screening.
In 2009, Kevin Cook and his colleagues at the Bloomington
stock center replaced the old Bloomington kit with a new kit of 467
molecularly defined deletions [32,33]. They were not interested in
phenotype when they created this kit, but only in maximum
coverage by a minimum number of Dfs. Our project was carried
out independently of their work, screening new Dfs for phenotype
and adding them to our kit as they were generated by the
community. Thus, although our kit is almost entirely composed of
lines available from Bloomington, only 31% of the lines in our kit
are in the new Bloomington Df mapping kit. Since we retained Dfs
from the old Bloomington kit for which homozygote embryos
developed well, our complete kit contains 185 lines for which the
Dfs are still not molecularly mapped. In the past, this would have
made gene localization under the Dfs difficult. Now, however,
because so many molecularly mapped Dfs are available, if one
finds a ‘hit’ with a Df mapped only to cytological resolution,
overlapping molecularly mapped Dfs can immediately be obtained
and screened in order to localize the relevant gene to a molecularly
defined interval.
To screen the genome for orphan receptor ligands, the first step
is to generate fusions of the XC domain of the receptor of interest
to AP, an obligate dimer [13]. These dimeric fusion proteins are
expressed at high levels using the baculovirus system, and
unpurified supernatants are used directly for staining. Live-
dissected embryos of various ages are incubated with fusion
protein supernatants, followed by fixation, anti-AP secondary
antibody, and tertiary fluorescent antibody. Once robust staining
of a potential ligand(s) has been obtained, the Df collection is
screened by double-staining with receptor fusion protein and a
monoclonal antibody that recognizes the tissue in which the ligand
is expressed. This is necessary in order to ensure that the absence
of staining in homozygotes for a particular Df is not due to the
absence of the relevant tissue. Some advantages of this method
over other ways of identifying orphan receptor ligands, such as
cDNA expression cloning in mammalian cell systems, include: 1)
since it is a search for genes that are necessary for ligand
expression, not genes sufficient for expression, it can identify
components of multimeric ligands, which could not be found by
expression cloning; 2) its success does not depend on the
abundance of the mRNA encoding the ligand(s); and 3) the screen
identifies not only the ligand genes themselves, but other genes
required for ligand expression or localization. For example, in the
screen that identified Syndecan, we also found genes encoding
modification enzymes necessary for HSPG synthesis [11].
This same type of screen can also identify genes required for
expression or localization of any antigen recognized by a high-
quality antibody. In our screen, we found Dfs that eliminated
expression of the FasII protein. We also found Dfs that caused
FasII to be expressed in different cell types than in wild-type
embryos (Figure 6). The responsible genes under these Dfs might
encode transcription factors necessary for FasII mRNA expression,
or proteins required for transport of FasII to the cell surface.
The complete kit could also facilitate identification of genes
required for appropriate subcellular localization of a protein. For
example, if one screened with an antibody recognizing an apical
protein, one could find genes necessary for its localization to the
apical side of the cell. One could also screen for genes necessary
for delivery of proteins to axons or dendrites. Kit screening could
also be done using fluorescent in situ hybridization. This would
allow identification of genes required for appropriate expression of
a transcript, even if one does not have a good antibody against the
protein encoded by the transcript.
Using subset kits to screen for phenotypes
We systematically examined the subset kit of ‘mild’ Df lines for
motor axon phenotypes, and defined 20 Dfs that cause SNa
bifurcation defects, 9 that produce ISNb defects, and others that
cause ISN and SNc defects. At least 24 produce muscle
phenotypes (Table 1, Table S3). We also found many lines with
specific CNS axon defects (Figure 2).
The identification of 9 regions selectively affecting ISNb
guidance within the ,40% of the genome covered by the mild
Dfs we screened suggests that there might be a total of ,22 genes
with ISNb-specific loss-of-function (LOF) phenotypes in the whole
genome. This seems like a surprisingly small number of genes, but
it is important to note that single mutations in many axon
guidance genes produce only low-penetrance defects. Deletion of
such genes might produce no phenotype, or a phenotype whose
penetrance would fall below the threshold (,20%) required for us
to classify the Df as abnormal. For example, loss of either Ptp69D
or Ptp99A produces weak ISNb phenotypes, but a double mutant
has strong phenotypes [34,35]. robo2 (leak) mutants have weak CNS
phenotypes, but robo2 mutations strongly enhance the robo
phenotype, so that the robo robo2 double mutant phenotype
resembles that of slit [36]. Thus, because of genetic redundancy,
there are probably many genes involved in axon guidance that
cannot be discovered by LOF screens. Such genes must be
identified by candidate gene approaches, like those used to find
Ptp69D, Ptp99A, and robo2, or by conducting enhancer/suppressor
screens.
The problem of genetic redundancy can be sometimes be
addressed using Dfs, since closely related genes are often located
near each other. One of the regions we identified as affecting ISNb
guidance contains gcm and gcm2, which encode transcription
factors that contribute to glial cell fate determination. When both
gcm and gcm2 are deleted, there are no glia at all, and development
of the RP cell bodies and axon tracts is abnormal (Figure 5). In
some segments, the ISNb is completely absent because no RP
axons leave the CNS. In others, the ISNb appears to stall, possibly
due to the absence of the RP axons that normally innervate
muscles 12 and 13. ISNb bypass phenotypes could be due to the
absence of glial cells near the exit junction that are required for
normal separation of the ISNb and ISN axons. These ISNb
phenotypes were not found before because embryos lacking both
Gcm proteins had never been examined for motor axon defects.
They are almost never observed when only gcm is mutant, perhaps
because a few glia are still present in these mutants due to Gcm2
expression.
The use of Dfs allowed us to uncover the roles of Gcm proteins
in motor axon guidance. However, in some cases Df phenotypes
are observed that are not due to loss of a single gene, and cannot
be so easily assigned to loss of a cluster of related genes. In such
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instances, it could be difficult to identify the specific combination
of genes whose loss causes the phenotype.
The use of the Df kit has also allowed us to discover phenotypes
that had not been seen previously. These include the looped ISNb
phenotype (Figure 4), SNc-specific phenotypes, and new phenotypes
affecting multiple motor axon pathways. Since most tissues appear
to develop normally in homozygotes for mild Dfs, this kit should
provide a valuable resource for other groups that are interested in
screening for new phenotypes affecting any embryonic organ. The
only requirement for performance of such a screen is a good
antibody that recognizes structures within the tissue in question.
Such screens can systematically survey,50% of the genome for any
phenotype that can be visualized at high magnification under a
compound or confocal microscope. A single person could conduct
such a screen in a period of months, making it a much less daunting
project than the execution of an EMS or P element screen.
Materials and Methods
Genetics
Most Df strains and mutants were obtained from the
Bloomington Stock Center. A few Df lines were obtained from
the Szeged and Kyoto Stock Centers. Deficiency kit lines were
balanced over FM7c, P(Gal4-Kr.C)DC1, P(UAS-GFP.S65T)DC5,
sn-, CyOarmGFP, TM3armGFP, CyO-Wingless-LacZ, or Tm6B-
Ubx-LacZ (Bloomington).
Overview of screening procedures
For identification of homozygote embryos, Dfs are placed over
GFP balancer chromosomes, so that Df/Df embryos can be
recognized prior to dissection. 29 Dfs on the X, 2nd, and 3rd
chromosomes cannot be maintained over these balancers and
must be screened blind. There are also 9 4th chromosome Dfs that
lack GFP balancers.
To screen the kit for ligand or antigen expression, one collects
embryos from groups of up to 10 lines at a time, sorts them for
GFP expression, lines up GFP-minus embryos in rows on a glass
slide, and dissects 4 or 5 embryos for each line. If the Dfs are being
screened for antigen expression or phenotype, they are immedi-
ately fixed and stained with the appropriate antibody. If a ligand
screen is being conducted, the embryos are first incubated live with
receptor fusion proteins, followed by fixation and detection of
fusion protein binding with secondary and tertiary antibodies [11].
To facilitate screening, we have published a detailed video
protocol for sorting, live dissection, and staining of embryos [12].
Immunohistochemistry/immunofluorescence and
microscopy
GFP fluorescence from the balancer chromosome was scored
using an Olympus GFP dissecting microscope. For 1D4
fluorescent staining, embryos are dissected live on glass slides,
fixed and washed in PBS. Embryos are then washed in PBS +0.5%
Triton (PBT), blocked with PBT +5% heat-inactivated normal
goat serum (NGS) and incubated overnight in a dilution of 1:3
1D4 in PBT +5% NGS. After washing in PBT embryos are
incubated at 4C overnight in AlexaFluor anti-mouse 488
secondary antibody and rhodamine-phalloidin (Invitrogen). For
fusion protein staining, embryos are incubated in fusion protein for
2 hours after dissection in the absence of detergent. Samples are
fixed, washed, and incubated in rabbit-anti-AP and BP102
overnight at 4uC and then processed with appropriate secondary
antibodies. Samples are mounted in 70% glycerol in PBS.
Fixed embryo immunohistochemistry was performed as previ-
ously described [3]. Briefly, after fixation embryos are extensively
washed in PBS +0.5% Triton (PBT), incubated overnight at 4uC in
PBT +5% heat-inactivated goat serum (HIGS) with a 1:5 dilution
of 1D4 antibody plus 1:5000 dilution of rabbit-anti-beta-
galactosidase antibody (MP Biomedicals) to label embryos carrying
the balancer chromosomes. Embryos are extensively washed in
PBT and then incubated overnight at 4uC in PBT +5% HIGS
with 1:500 dilutions of horseradish peroxidase-conjugated goat-
anti-mouse and goat anti-rabbit (Jackson Immunoresearch). After
extensive washing in PBT, the peroxidase reaction was carried out
using a DAB peroxidase substrate kit (Vector Laboratories), and
the embryos were mounted in 70% glycerol and dissected.
Embryos were scored for fusion protein staining, motor axon
defects, CNS defects, and muscle defects on a Zeiss Axioplan
microscope with a 406multi-immersion objective. Screening for
CNS, motor axon, and muscle defects was conducted by scoring 5
homozygous deficiency embryos per stock. Abdominal hemiseg-
ments A2–A7 were scored. Quantitative data was obtained by
analyzing 1D4 HRP immunoreactivity. Homozygous deficiency
embryos were scored blind for axon guidance defects in abdominal
hemisegments A3–A7.
The following antibodies were used rabbit anti-AP (Serotec)
1:600, mAb bp102 1:30, mAb 1D4 1:3, mAb7G10 1:5 (Caltech
Monoclonal Antibody Facility), AlexaFluor anti-mouse 488, Alexa
Fluor anti-mouse 568, and AlexaFluor anti-rabbit 488 (Invitrogen)
1:1000. Horseradish peroxidase-conjugated goat-anti-mouse and
goat anti-rabbit (Jackson Immunoresearch) 1:500. Rhodamine-
phalloidin (Invitrogen) was used at 1:2000 to detect muscle
structure.
Confocal imaging was performed using a Zeiss LSM inverted
microscope using 206, 406, and 636 Zeiss oil-immersion
objectives. Stacks were projected using Image J software maximum
intensity projections.
Supporting Information
Table S1 Headings for columns A-D are self-evident or are
explained in the paper text. For the other columns, ‘m’ (column E)
refers to whether a Df is molecularly mapped. ‘o’ (column F) is the
suggested order of kit screening, where (1) is the collection of Dfs
that are mild, moderate, or severe and are balanceable over GFP,
(2) is the collection of Dfs that are balanceable over GFP but may
be redundant with (1), (3) are Dfs that can’t be balanced over GFP,
and (4) are very severe Dfs that are only marginally screenable.
Mild Dfs are those which have a normal BP102 ladder and normal
overall body wall structure; moderate Dfs are those which have
some visible abnormalities in the CNS axon ladder; severe Dfs are
those which have a disorganized CNS but still contain large
numbers of axons; very severe Dfs are those which have highly
disorganized CNS structure usually with few axons and overall
structure of the embryo is abnormal. Annotation of lines as DK1,
DK2, and DK3 refers to the old (2002) Df kit from the
Bloomington Stock Center, not the new molecularly mapped kit.
‘Notes on lines’ (column G) contains useful information about the
Dfs and the reasons for their incorporation into the kit; it also
contains instructions for screening nonbalanceable Df lines, and
notes on regions covered only by Dfs that cannot be screened.
‘Further notes on mapping’ (column H) contains complementation
data and overlap information from the old Bloomington kit.
Found at: doi:10.1371/journal.pone.0012288.s001 (0.10 MB
XLS)
Table S2 The ‘mild’ subset of the deficiency kit
Found at: doi:10.1371/journal.pone.0012288.s002 (0.05 MB
XLS)
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Table S3 Headings for columns A and B are self-evident. ‘Notes’
(Column C) contains information about the phenotype of the Df
such as the affected motor pathway, muscle defect, or Dfs which
are developmentally delayed.
Found at: doi:10.1371/journal.pone.0012288.s003 (0.03 MB
XLS)
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